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Kidney Transplantation (KTx) is a treatment of choice for patients with end-stage renal disease (1,2). KTx improves most of the metabolic disturbs (1). Post-transplant bone 
disease is a heterogeneous problem due to various factors, 
consisting gender, age, presence of hyperparathyroidism, 
corticosteroids and treatment with calcineurin inhibitors (1,2). 
Indeed, it is essential to test parathyroid gland function as a 
regular follow up of these patients. In this study, we aimed to 
consider the post-transplant function of parathyroid gland in a 
group of KTx patients.
Patients and Methods
Patients
This cross-sectional study was performed on a group of renal 
transplanted recipients. Exclusion criteria were presence of 
acute rejection, infection, antibiotic taking during the past 
two months. The immunosuppressive protocol of the patients 
contained of a combination of prednisolone 7.5 mg/d for all of 
the patients, cyclosporine at a mean dosage of 190±60 mg/d, 
and mycophenolate mofetile in 46% of the patients at a dosage 
of 1500 ±500 mg/d /or azathioprine at a dosage of 50 to 100 
mg/d in the rest of the patients. 
Laboratory methods
Serum intact parathormone (iPTH) levels were measured after 
an overnight fast. iPTH was measured by Radioimmunoassay 
method (normal range of values: 10-65 pg/mL). Blood samples 
were collected also for biochemical analysis including serum 
creatinine, blood urea nitrogen (BUN), levels, using standard 
kits. Creatinine clearance was assessed from serum creatinine, 
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This investigation, aimed to study of intact parathormone (iPTH) and calcium (Ca) in a group of kidney 
transplanted patients and also we aimed to test the relationship of iPTH with various demographic data 
of kidney transplanted recipients. We studied 72 kidney transplanted persons with mean ages of 44±12 
years. In this study, mean iPTH was 18.4±8.2 Pg/mL (median=16.5). A negative correlation of iPTH 
with creatinine clearance (r=-0.44, p<0.001) was seen. There was no any association between the time of 
kidney transplantation and serum iPTH (p>0.05). In contrast to previous findings, in our patients, there 
was not secondary hyperparathyroidism. The results revealed suppressed PTH secretion. The reason 
may be due to excessive intake of calcium and Vitamin D analogues, which may suppress parathyroid 
hormone secretion.
Implication for health policy/practice/research/medical education:
In a study on 72 kidney-transplanted persons with mean ages of 44±12 years. The mean intact PTH was 18.4±8.2 Pg/mL (median=16.5). A 
negative correlation of intact PTH with creatinine clearance (r=-0.44, p<0.001) was seen. There was no any association between the time of kidney 
transplantation and serum iPTH (p>0.05). In contrast to previous publications, in our patients, there was not secondary hyperparathyroidism. 
The results revealed suppressed PTH secretion. The reason may be due to excessive intake of calcium and vitamin D analogues, which may 
suppress parathyroid hormone secretion.
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age and body weight (3).
Ethical approval
All patients signed the consent form for participation in this 
study. Research study was approved by the ethics committee of 
Shahrekord University of Medical Sciences, Iran.
Statistical Analysis
Descriptive results were expressed as the mean±SD and 
median values. For correlations, partial correlation test was 
used. Comparisons between groups were done using student’s 
t-test. For normalization of the iPTH data, their second square 
values were used. All statistical analysis were performed with 
the SPSS 12 (SPSS Inc., Chicago, USA). Statistical significance 
was determined at a p<0.05.
Results
A total of 72 patients were included to this study (47 male, 25 
female). The mean patients’ age was 44±12 years. The mean 
time of KTx was 67.5±42 months Mean serum iPTH was 
18.4±8.2 Pg/mL. In this study an inverse association of serum 
iPTH with creatinine clearance (r=-0.44, p<0.001) was found. 
No significant association between the duration KTx and 
serum iPTH (p>0.05) was seen. 
Discussion
In the present study, we found an inverse association of iPTH 
with creatinine clearance. There was not any significant 
association between the duration of KTx and iPTH. Our 
patients’ mean intact parathormone was 18.4 (±8.2) pg/mL, 
which referred to the suppressed level of parathormone. The 
cause may be due to excessive intake of vitamin D and calcium 
analogues. In fact, secondary hyperparathyroidism is a 
common complication in patients with chronic kidney disease 
(4–8). Renal transplantation improves the abnormalities 
responsible for secondary hyperparathyroidism in the first 
months (8–10). Nevertheless, elevated iPTH level has been 
found in >25% of patients one year after renal transplantation 
in the presence of good kidney function (8–11).
Conclusion
We concluded that, the reason of suppressed level of 
parathormone in our patients may be due to excessive intake 
of vitamin D and calcium analogues, which suppress the 
parathyroid gland secretion, and may susceptible these patients 
to a dynamic bone disease.
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